Literature DB >> 8340746

Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy.

A Gruber1, L G Lundberg, M Björkholm.   

Abstract

A patient with immune-mediated thrombocytopenia (ITP) and chronic hepatitis C virus (HCV) infection for 11 years was given immunosuppressive treatment because of an activation of his ITP. After 6 weeks of treatment with cyclophosphamide, cyclosporin A and cortisone the patient decided not to continue taking his medication. One month later he was readmitted to hospital due to fever, cough and jaundice. Clinical investigation revealed his condition to be caused by an activation of his HCV infection. It is concluded that, in parallel to the situation in hepatitis B, immunosuppressive treatment of patients with HCV infection may lead to increased viral replication, resulting in severe liver damage when immunocompetence is regained.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8340746     DOI: 10.1111/j.1365-2796.1993.tb00734.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  5 in total

Review 1.  Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

Authors:  Harrys A Torres; Marta Davila
Journal:  Nat Rev Clin Oncol       Date:  2012-01-24       Impact factor: 66.675

2.  Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease.

Authors:  H L Tillmann; D F Chen; C Trautwein; V Kliem; A Grundey; A Berning-Haag; K Böker; S Kubicka; L Pastucha; W Stangel; M P Manns
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

3.  Spontaneous resolution of systemic sarcoidosis in a patient with chronic hepatitis C without interferon therapy.

Authors:  Tae-Hun Kim; Jong-Eun Joo
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

Review 4.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

5.  Therapeutic Dilemma of Sarcoidosis and Treatment-naïve Hepatitis C Manifesting as Tattoo Reactions.

Authors:  Naoto Ishimaru; Jun Ohnishi; Hiroyuki Seto; Yohei Kanzawa; Nobuya Sano; Saori Kinami
Journal:  Intern Med       Date:  2020-09-30       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.